Expression and clinical significance of Caveolin-1 in prostate Cancer after transurethral surgery
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12894-018-0418-4.pdf
Reference32 articles.
1. Wong ECL, Kapoor A. Epidemiology of prostate and kidney cancer in the aboriginal population of Canada: a systematic review. Can Urol Assoc J. 2017;11:E222–E32.
2. Trama A, Botta L, Nicolai N, Rossi PG, Contiero P, Fusco M, et al. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study. Eur J Cancer. 2016;67:91–8.
3. Rainato G, Fabricio AS, Zancan M, Peloso L, Dittadi R, Barichello M, et al. Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis. Int J Biol Markers. 2016;31:e317–e23.
4. Stephan C, Jung K, Miller K, Ralla B. New biomarkers in serum and urine for detection of prostate cancer. Aktuelle Urol. 2015;46:129–43.
5. Dickinson J, Shane A, Tonelli M, Connor GS, Joffres M, Singh H, et al. Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening. Cmaj Open. 2016;4:E73–E9.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Caveolin-1‘s dual impact on endometrioid endometrial carcinoma: a histopathological and immunohistochemical study;Journal of Immunoassay and Immunochemistry;2024-04-16
2. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer—Evidence from Serbian Population;International Journal of Molecular Sciences;2024-03-21
3. Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer;Discover Oncology;2023-11-01
4. The intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate cancer progression;Reproduction, Fertility and Development;2023-05-23
5. The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial;PLOS ONE;2022-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3